EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte Studie

Tranexamic Acid in Rhytidectomy: A Split-Face Multi-Institutional Study

Jaclyn A Klimczak iD, Manoj Abraham iD, Shirley Hu, Daniel E Rousso, Stephen Perkins, Mark Hamilton iD

Facial Plastic Surgery & Aesthetic Medicine · 2025

DOI: 10.1089/fpsam.2024.0008 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Facial Plastic Surgery & Aesthetic Medicine, 2025. Verfasst von Jaclyn A Klimczak und 5 weiteren Autor:innen. Beteiligte Einrichtung: Facial Surgery Institute of Boca Raton, Boca Raton, Florida, USA. Hauptthemen laut MEDLINE: Tranexamic Acid, Rhytidoplasty, Ecchymosis, Antifibrinolytic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tranexamic acid (TXA) has the ability to reduce intraoperative bleeding and facilitate hemostasis in addition to its anti-inflammatory properties that can potentially aid in recovery among patients who underwent rhytidectomy.

Objective

To compare postoperative ecchymosis in patients who underwent rhytidectomy with TXA added to the tumescent anesthetic.

Methods

A multi-institutional, single-blind study was performed on patients who underwent rhytidectomy. The sidedness of the face was randomized to receive either local anesthetic with TXA or without, prior to incision for rhytidectomy. The primary outcome was postoperative ecchymosis that was graded by the surgeons at the 1 week postoperative time frame in standard photograph review.

Results

A total of 70 patients, mean age 62.1, were enrolled in the study. The surface area of postoperative ecchymosis at 1 week was shown to be significantly less on the side of the face that received local anesthetic infiltration prior to incision with TXA than the side that had local anesthetic without TXA (p < 0.001). These results were consistent with subjective measurements of postoperative ecchymosis graded at 1 week with two blinded investigators to the sidedness of the face that received TXA (p < 0.001).

Conclusions

TXA may potentially facilitate a reduction in postoperative ecchymosis in patients undergoing rhytidectomy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tranexamic AcidRhytidoplastyEcchymosisAntifibrinolytic AgentsBlood Loss, SurgicalHumansMiddle AgedFemaleSingle-Blind MethodMaleAgedAnesthetics, LocalAnesthesia, LocalTreatment OutcomeAdult

Substanzen

Tranexamic AcidAntifibrinolytic AgentsAnesthetics, Local

Autor:innen und Institutionen

  • Facial Surgery Institute of Boca Raton, Boca Raton, Florida, USA.
  • Mount Sinai Facial Plastic Surgery, Poughkeepsie, New York, USA.
  • Airem Facial Plastic Surgery, Syosset, New York, USA.
  • Rousso Adams Facial Plastic Surgery, Birmingham, Alabama, USA.
  • Meridian Plastic Surgeons, Indianapolis, Indiana, USA.
  • Hamilton Facial Plastic Surgery, Greenwood, Indiana, USA.

ORCID-Profile: Jaclyn A Klimczak, Manoj Abraham, Mark Hamilton

Zitieren

APA

Klimczak, J. A., Abraham, M., Hu, S., Rousso, D. E., Perkins, S., & Hamilton, M. (2025). Tranexamic Acid in Rhytidectomy: A Split-Face Multi-Institutional Study. Facial Plastic Surgery & Aesthetic Medicine. https://doi.org/10.1089/fpsam.2024.0008

Vancouver

Klimczak JA, Abraham M, Hu S, Rousso DE, Perkins S, Hamilton M. Tranexamic Acid in Rhytidectomy: A Split-Face Multi-Institutional Study. Facial Plastic Surgery & Aesthetic Medicine. 2025. doi:10.1089/fpsam.2024.0008

BibTeX
@article{Klimczak2025,
  author = {Klimczak, Jaclyn A and Abraham, Manoj and Hu, Shirley and Rousso, Daniel E and Perkins, Stephen and Hamilton, Mark},
  title = {Tranexamic Acid in Rhytidectomy: A Split-Face Multi-Institutional Study},
  journal = {Facial Plastic Surgery & Aesthetic Medicine},
  year = {2025},
  doi = {10.1089/fpsam.2024.0008}
}
Kostenlos starten →